Print

Print


Hello all,

The last week several lists have been posted about meds that
are contra-indicated in combination with PD or PD-meds.
All lists were different!! Rather confusing I think.....

I have compared these 3 lists:

A   the APDA-list (the orange card).
    [re-posted by me]

B   the list of medications published in the June 1998
    Newsletter of the NPF support group that meets at
    Georgetown University Hospital (In Washington DC).
    [re-posted by Hilary Blue]

C   the list on John Cottingham's site (updated 02/21/98).
    [re-posted by Ron Vetter]

There were several names of meds (generic and/or brandnames)
misspelled. Also were some meds mentioned on one list, but NOT
on the other list(s). It seems important enough to investigate
the differences. If you know of other lists like the ones
mentioned, could you send them to me directly OFF-LIST, so I
can compare them also. Can someone tell me if there is such a
list on the ParkinsonAlliance-site, or on the PD-Drugdatabase,
a national list from the NPF???

I plan to compare (all) relevant lists, and post the (final)
results on this PD-list.

Then it seems logical to gather ALL (if possible) meds that
are contra-indicated, but are NOT on any of these lists yet.

Finally this combined list plus the extra gathered meds plus
the questions that no doubt will arise in the process, could
be presented to a forum of experts, the APDA, the NPF, etc.
for evaluation.

The endresult of it all will hopefully be ONE UNIFIED LIST
with all contra-indicated meds on it!!!!!

Comments, ideas, etc. are welcome!!

I'm now posting only the misspelled names and the differences
between the 3 lists. If people that have access to the original
lists would be so kind to check whether the misspelling is
made in the posted list or in the original list. In that way
we can correct/adjust the postings/lists. Please email your
findings OFF-LIST to me!! Thank you!

Hans.

     # # # # # # # # # # # # # # # # # # # # # # # #

Here we go:

A = APDA-list
B = "BLUE"/NPF-Washington DC
C = "COTTINGHAM"/"VETTER"

CORRECTIONS:

C       Hadol               must be     Haldol
C       Stalzine            must be     Stelazine
B       Proloxin            must be     Prolixin

A       Flufenazine         \
B       Fluophenazine        >  which is correct?
C       Fluphenazine        /

A       Thiothixene         must be     Thiothixine
B       oxapine             must be     Loxapine (HCL)
C       Loxapine            must be     Loxapine (HCL)

B       Pheylzene           must be     Phenelzine
C       Tranycypromine      must be     Tranylcypromine

A       Porchlorperazine    \   which is
B+C     Prochlorperazine    /       correct?

C       Reserpin            must be     Reserpine
C       Rescinamine         must be     Rescinnamine
B       Meperidene          must be     Meperidine

A       Buspirone           \
B       Busparone            >  which is correct?
C       Subpirone           /

B       Parixetine          must be     Paroxetine


EXTRA on the "B"-list (compared to the "A"-list) are:

    BRAND NAMES                     GENERIC
    Moban                           malindone
    Ser-Ap-Es                       -
    Diutensin                       -
    Diupres                         -
    Demi-Regroton                   -
    Salutensin                      reserpine
    pavabid                         papaverine
    Lithobid                        Lithium carbonate
    Taractan                        chlorprothixene
    Elavil                          amitriptyline hydrochloride
    Paxil                           paroxetine
    Prozac                          fluoxetine
    Zoloft                          sertraline


EXTRA on the "C"-list (compared to the "A"-list) are:

    Trade               Generic

    Orap                Pimozide
    Serentil            Mesoridazine
    Taractan            Chlorprothixene
    Tindal              Acetaphenazine
    Vesprin             Triflupromazine
    Niacin
    B-Complex vitamins
    Nicotinomide
    Lithobid

        # # # # # # # # # # # # # # # # # # # #